Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 51.73% is 285% above its 5-year average of -27.94%, near the high end of its 5-year range (-96.45%–83.11%).
1346.90% above its 12-month average of 3.58%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 45.73%.
EBITDA MARGIN
51.73%
EBITDA MARGIN AVG TTM
3.58%
EBITDA MARGIN AVG 3Y
-6.43%
EBITDA MARGIN AVG 5Y
-27.94%
EBITDA MARGIN AVG 10Y
-44.27%
EBITDA MARGIN AVG 15Y
-67.36%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1346.90%
CURRENT VS 3Y AVG
+904.37%
CURRENT VS 5Y AVG
+285.17%
CURRENT VS 10Y AVG
+216.84%
CURRENT VS 15Y AVG
+176.79%
CURRENT VS 20Y AVG
N/A
PTC Therapeutics, Inc.
Market Cap
$5.29B
EBITDA Margin
51.73%
TTM Avg
3.58%
3Y Avg
-6.43%
5Y Avg
-27.94%
Market Cap
$5.21B
EBITDA Margin
45.70%
TTM Avg
43.81%
3Y Avg
42.07%
5Y Avg
42.46%
Market Cap
$5.21B
EBITDA Margin
-15636.44%
TTM Avg
-8457.23%
3Y Avg
-41454.98%
5Y Avg
-35632.55%
Market Cap
$5.20B
EBITDA Margin
-0.42%
TTM Avg
-60.31%
3Y Avg
-158.65%
5Y Avg
-142.10%
Market Cap
$5.19B
EBITDA Margin
-1035.18%
TTM Avg
-586.23%
3Y Avg
-456.90%
5Y Avg
-388.23%
Market Cap
$5.52B
EBITDA Margin
1.58%
TTM Avg
-0.29%
3Y Avg
0.97%
5Y Avg
0.97%
Market Cap
$5.07B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$5.07B
EBITDA Margin
-395.82%
TTM Avg
-536.17%
3Y Avg
-471.62%
5Y Avg
-471.62%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.29B | 51.73% | 3.58% | -6.43% | -27.94% |
| Sotera Health Company (SHC)vs › | $5.21B | 45.70% | 43.81% | 42.07% | 42.46% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -15636.44% | -8457.23% | -41454.98% | -35632.55% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.20B | -0.42% | -60.31% | -158.65% | -142.10% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 35.56% | 38.69% | 36.58% | 34.55% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | -1035.18% | -586.23% | -456.90% | -388.23% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 1.58% | -0.29% | 0.97% | 0.97% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 21.06% | 20.50% | 18.63% | 16.67% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.07B | -395.82% | -536.17% | -471.62% | -471.62% |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 35.46% | 34.17% | 36.83% | 37.63% |
Gross Margin
95.8%
EBITDA Margin
51.7%
Operating Margin
49.5%
Net Margin
-3.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 45.73% |
| 2026-03-31 | 22.49% |
| 2025-12-31 | -41.73% |
| 2025-09-30 | 6.69% |
| 2025-06-30 | -15.30% |
| 2025-03-31 | 83.11% |
| 2024-12-31 | -73.00% |
| 2024-09-30 | -24.40% |
| 2024-06-30 | -17.78% |
| 2024-03-31 | 4.73% |
| 2023-12-31 | 27.30% |
| 2023-09-30 | -27.28% |
| 2023-06-30 | -74.15% |
| 2023-03-31 | -33.94% |
| 2022-12-31 | -96.45% |
| 2022-09-30 | -16.49% |
| 2022-06-30 | -38.17% |
| 2022-03-31 | -40.48% |
| 2021-12-31 | -39.90% |
| 2021-09-30 | -55.01% |
| 2021-06-30 | -71.57% |
| 2021-03-31 | -71.70% |
| 2020-12-31 | -70.65% |
| 2020-09-30 | -36.73% |
| 2020-06-30 | -235.33% |
| 2020-03-31 | -122.70% |
| 2019-12-31 | -65.84% |
| 2019-09-30 | -73.28% |
| 2019-06-30 | -36.31% |
| 2019-03-31 | -117.69% |
| 2018-12-31 | -45.26% |
| 2018-09-30 | -76.80% |
| 2018-06-30 | 0.94% |
| 2018-03-31 | -19.12% |
| 2017-12-31 | 13.94% |
| 2017-09-30 | -49.21% |
| 2017-06-30 | -24.31% |
| 2017-03-31 | -96.97% |
| 2016-12-31 | -95.98% |
| 2016-09-30 | -135.96% |
| 2016-06-30 | -228.65% |
| 2016-03-31 | -198.96% |
| 2015-12-31 | -372.26% |
| 2015-09-30 | -424.31% |
| 2015-06-30 | -595.81% |
| 2015-03-31 | -692.38% |
| 2014-12-31 | -273.13% |
| 2014-09-30 | -3394.98% |
| 2014-06-30 | -1749.44% |
| 2014-03-31 | -148.95% |
| 2013-12-31 | -445.38% |
| 2013-09-30 | -23.86% |
| 2013-06-30 | -236.13% |
| 2013-03-31 | -130.95% |
| 2012-12-31 | -90.88% |
| 2012-09-30 | -105.71% |
| 2012-06-30 | -112.40% |
| 2012-03-31 | -51.34% |
